By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


 

Immune Design Corporation 

1102 Columbia Street
Suite 104
Seattle  Washington  98104  U.S.A.
Phone: n/a Fax: n/a


SEARCH JOBS


Industry
Biotechnology

Segment
Start Up





Company News
Immune Design Corporation (IMDZ) Receives Orphan Drug Designation From The U.S. FDA For Complementary Components Of CMB305 1/11/2016 8:09:58 AM
Immune Design Corporation (IMDZ) Highlights G100 Preclinical Data Demonstrating Direct And Abscopal Tumor Regression, Long-Term Response And Synergy With Checkpoint Blockade 12/8/2015 1:58:37 PM
Immune Design Corporation (IMDZ) Highlights G100 Preclinical Data Demonstrating Direct And Abscopal Tumor Regression, Long-Term Response And Synergy With Checkpoint Blockade 12/8/2015 9:56:28 AM
Immune Design Corporation (IMDZ) Reports Third Quarter 2015 Financial Results 11/13/2015 8:22:22 AM
Immune Design Corporation (IMDZ) To Present At Jefferies Autumn 2015 Global Healthcare Conference In London 11/11/2015 10:20:43 AM
Immune Design Corporation (IMDZ) Announces Start Of Randomized Phase II Cancer Immunotherapy Combination Trial In Patients With Soft Tissue Sarcoma 11/11/2015 10:14:49 AM
Immune Design Corporation (IMDZ) To Report Third Quarter 2015 Financial Results 11/6/2015 7:21:45 AM
Immune Design Corporation (IMDZ) Announces Oral Presentation Of G100 Product Candidate Preclinical Data At American Society of Hematology Annual Meeting 11/5/2015 8:41:49 AM
Immune Design Corporation (IMDZ) Presents Preclinical Data On G100 And ZVex In Combination With Check Point Inhibitors At The 2015 Society For Immunotherapy Of Cancer Annual Meeting 11/3/2015 7:45:33 AM
MEDI7510 For Respiratory Syncytial Virus Advances To Phase II Leverages Immune Design Corporation (IMDZ)'s GLAAS(TM) Discovery Platform 10/29/2015 9:11:40 AM
1234567
//-->